Health Care: Drugs

Cyclacel Pharmaceuticals Inc (CYCC: NASDAQ)

$0.9556 n/a | n/a%
04/24/15 - 03:59 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 1.73M 1.08M 69.00K 699.00K
Cost of Sales 0.00 0.00 0.00 119.00K
Gross Operating Profit 1.73M 1.08M 69.00K 580.00K
Selling, General, and Administrative Expenses 5.89M 7.78M 8.58M 7.52M
Research & Development 18.28M 11.28M 6.59M 9.21M
Operating Income before D & A (EBITDA) -22.44M -17.97M -15.10M -16.15M
Depreciation & Amortization 174.00K 70.00K 60.00K 241.00K
Interest Income 6.00K 13.00K 22.00K 45.00K
Other Income - Net -218.00K 6.08M -26.00K 535.00K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -22.82M -11.95M -15.17M -15.81M
Interest Expense 0.00 0.00 0.00 0.00
Pre-Tax Income -22.82M -11.95M -15.17M -15.81M
Income Taxes -3.24M -1.67M -1.35M -565.00K
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -19.41M -10.21M -13.76M -15.24M
Net Income From Discontinued Operations 19.00K 57.00K 570.00K 0.00
Net Income From Total Operations -19.39M -10.15M -13.19M -15.24M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -19.39M -10.15M -13.19M -15.24M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-19.41M -10.21M -13.76M -15.24M
Preferred Dividends
Net Income Available To Common -19.61M -19.54M -14.48M -15.97M
Basic EPS from Continuing Ops. -0.89 -1.29 -1.75 -2.22
Basic EPS from Discontinued Ops. 0.00 0.00 0.07 0.00
Basic EPS from Total Operations -0.89 -1.28 -1.68 -2.22
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 -0.02
Basic EPS, Total -0.89 -1.28 -1.68 -2.24
Basic Normalized Net Income/Share -0.89 -1.29 -1.75 -2.22
EPS fr Continuing Ops. -0.89 -1.29 -1.75 -2.22
EPS fr Discontinued Ops 0.00 0.00 0.07 0.00
EPS fr Total Ops. -0.89 -1.28 -1.68 -2.22
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 -0.02
EPS, Total -0.89 -1.28 -1.68 -2.24
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.89 -1.29 -1.75 -2.22
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with CYCC

Latest CYCC Headlines from TheStreet

More Financial News for CYCC

Press Releases for CYCC

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter